Display options
Cite
Compston A. Selection of patients for clinical trials. Neuroepidemiology. 1987;6(1):34-9doi: 10.1159/000110098.
Compston, A. (1987). Selection of patients for clinical trials. Neuroepidemiology, 6(1), 34-9. https://doi.org/10.1159/000110098
Compston, A. "Selection of patients for clinical trials." Neuroepidemiology vol. 6,1 (1987): 34-9. doi: https://doi.org/10.1159/000110098
Compston A. Selection of patients for clinical trials. Neuroepidemiology. 1987;6(1):34-9. doi: 10.1159/000110098. PMID: 3627343.
Copy Download .nbib Format: NLM
Share it on
Full text links
S. Karger AG, Basel, Switzerland

Neuroepidemiology. 1987;6(1):34-9. doi: 10.1159/000110098.

Selection of patients for clinical trials.

Neuroepidemiology

A Compston

PMID: 3627343 DOI: 10.1159/000110098

Abstract

Since there is no treatment of proven value in patients with MS it is necessary still to select those patients for inclusion in clinical trials who have most to gain and can demonstrate rapidly the effectiveness or not of each new treatment. Experience gained in these trials can be then extrapolated to the disease as a whole.

Similar articles

MeSH terms

Publication Types

LinkOut - more resources